MyFinsight
Home
Blog
About
Cash and investments
held in trust account
$146,834,251
(-37.56%↓ Y/Y)
Prepaid expenses and
other current assets
$48,904
(0.00%↑ Y/Y)
Cash
$20,280
(2367.15%↑ Y/Y)
Total non-current
assets
$146,834,251
Total current assets
$69,184
(39.13%↑ Y/Y)
Total assets
$146,903,435
(-37.54%↓ Y/Y)
Accumulated deficit
-$7,407,288
(-14.72%↓ Y/Y)
Total liabilities,
ordinary shares subject...
$146,903,435
(-37.54%↓ Y/Y)
Total shareholders
deficit
-$7,406,216
(-3.56%↓ Y/Y)
Ordinary shares, 0.0001
par value...
$1,072
(1.90%↑ Y/Y)
Ordinary shares subject
to possible...
$145,173,027
(-38.27%↓ Y/Y)
Total liabilities
$9,136,624
(26.87%↑ Y/Y)
Total non-current
liabilities
$6,192,000
Total current
liabilities
$2,944,624
(876.85%↑ Y/Y)
Deferred underwriting
fee payable
$6,192,000
(-10.26%↓ Y/Y)
Share redemptions
payable
$1,661,224
Extension advance note
-$600,000
Interim note
$350,000
Accounts payable and
accrued expenses
$254,412
(72.54%↑ Y/Y)
Accrued offering costs
$78,988
(-48.71%↓ Y/Y)
Back
Back
Balance Sheet
Drugs Made In America Acquisition Corp. (DMAA)
Drugs Made In America Acquisition Corp. (DMAA)
source: myfinsight.com